Canavan disease

Mutations among Jewish and non-Jewish patients

Rajinder Kaul, Guang P. Gao, Maria Aloya, Kuppareddi Balamurugan, Arlene Petrosky, Kimberlee Michals, Reuben Matalon

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Canavan disease is an autosomal recessive leukodystrophy caused by the deficiency of aspartoacylase (ASPA). Sixty-four probands were analyzed for mutations in the ASPA gene. Three point mutations-693C→A, 854A→C, and 914C→A-were identified in the coding sequence. The 693C→A and 914C→A base changes, resulting in nonsense tyr231→ter and missense ala305→glu mutations, respectively, lead to complete loss of ASPA activity in in vitro expression studies. The 854A→C transversion converted glu to ala in codon 285. The glu285→ala mutant ASPA has 2.5% of the activity expressed by the wild-type enzyme. A fourth mutation, 433 -2(A→G) transition, was identified at the splice-acceptor site in intron 2. The splice-site mutation would lead to skipping of exon 3, accompanied by a frameshift, and thus would produce aberrant ASPA. Of the 128 unrelated Canavan chromosomes analyzed, 88 were from probands of Ashkenazi Jewish descent. The glu285→ala mutation was predominant (82.9%) in this population, followed by the tyr231→ter (14.8%) and 433 -2(A→G) (1.1%) mutations. The three mutations account for 98.8% of the Canavan chromosomes of Ashkenazi Jewish origin. The ala305→glu mutation was found exclusively in non-Jewish probands of European descent and constituted 60% of the 40 mutant chromosomes. Predominant occurrence of certain mutations among Ashkenazi Jewish and non-Jewish patients with Canavan disease would suggest a founding-father effect in propagation of these mutant chromosomes.

Original languageEnglish (US)
Pages (from-to)34-41
Number of pages8
JournalAmerican Journal of Human Genetics
Volume55
Issue number1
StatePublished - 1994
Externally publishedYes

Fingerprint

Canavan Disease
Mutation
Chromosomes
RNA Splice Sites
Missense Mutation
Point Mutation
Codon
Fathers
Introns
Exons

ASJC Scopus subject areas

  • Genetics

Cite this

Kaul, R., Gao, G. P., Aloya, M., Balamurugan, K., Petrosky, A., Michals, K., & Matalon, R. (1994). Canavan disease: Mutations among Jewish and non-Jewish patients. American Journal of Human Genetics, 55(1), 34-41.

Canavan disease : Mutations among Jewish and non-Jewish patients. / Kaul, Rajinder; Gao, Guang P.; Aloya, Maria; Balamurugan, Kuppareddi; Petrosky, Arlene; Michals, Kimberlee; Matalon, Reuben.

In: American Journal of Human Genetics, Vol. 55, No. 1, 1994, p. 34-41.

Research output: Contribution to journalArticle

Kaul, R, Gao, GP, Aloya, M, Balamurugan, K, Petrosky, A, Michals, K & Matalon, R 1994, 'Canavan disease: Mutations among Jewish and non-Jewish patients', American Journal of Human Genetics, vol. 55, no. 1, pp. 34-41.
Kaul R, Gao GP, Aloya M, Balamurugan K, Petrosky A, Michals K et al. Canavan disease: Mutations among Jewish and non-Jewish patients. American Journal of Human Genetics. 1994;55(1):34-41.
Kaul, Rajinder ; Gao, Guang P. ; Aloya, Maria ; Balamurugan, Kuppareddi ; Petrosky, Arlene ; Michals, Kimberlee ; Matalon, Reuben. / Canavan disease : Mutations among Jewish and non-Jewish patients. In: American Journal of Human Genetics. 1994 ; Vol. 55, No. 1. pp. 34-41.
@article{92f0480f83ea494d8eff990121b5d243,
title = "Canavan disease: Mutations among Jewish and non-Jewish patients",
abstract = "Canavan disease is an autosomal recessive leukodystrophy caused by the deficiency of aspartoacylase (ASPA). Sixty-four probands were analyzed for mutations in the ASPA gene. Three point mutations-693C→A, 854A→C, and 914C→A-were identified in the coding sequence. The 693C→A and 914C→A base changes, resulting in nonsense tyr231→ter and missense ala305→glu mutations, respectively, lead to complete loss of ASPA activity in in vitro expression studies. The 854A→C transversion converted glu to ala in codon 285. The glu285→ala mutant ASPA has 2.5{\%} of the activity expressed by the wild-type enzyme. A fourth mutation, 433 -2(A→G) transition, was identified at the splice-acceptor site in intron 2. The splice-site mutation would lead to skipping of exon 3, accompanied by a frameshift, and thus would produce aberrant ASPA. Of the 128 unrelated Canavan chromosomes analyzed, 88 were from probands of Ashkenazi Jewish descent. The glu285→ala mutation was predominant (82.9{\%}) in this population, followed by the tyr231→ter (14.8{\%}) and 433 -2(A→G) (1.1{\%}) mutations. The three mutations account for 98.8{\%} of the Canavan chromosomes of Ashkenazi Jewish origin. The ala305→glu mutation was found exclusively in non-Jewish probands of European descent and constituted 60{\%} of the 40 mutant chromosomes. Predominant occurrence of certain mutations among Ashkenazi Jewish and non-Jewish patients with Canavan disease would suggest a founding-father effect in propagation of these mutant chromosomes.",
author = "Rajinder Kaul and Gao, {Guang P.} and Maria Aloya and Kuppareddi Balamurugan and Arlene Petrosky and Kimberlee Michals and Reuben Matalon",
year = "1994",
language = "English (US)",
volume = "55",
pages = "34--41",
journal = "American Journal of Human Genetics",
issn = "0002-9297",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Canavan disease

T2 - Mutations among Jewish and non-Jewish patients

AU - Kaul, Rajinder

AU - Gao, Guang P.

AU - Aloya, Maria

AU - Balamurugan, Kuppareddi

AU - Petrosky, Arlene

AU - Michals, Kimberlee

AU - Matalon, Reuben

PY - 1994

Y1 - 1994

N2 - Canavan disease is an autosomal recessive leukodystrophy caused by the deficiency of aspartoacylase (ASPA). Sixty-four probands were analyzed for mutations in the ASPA gene. Three point mutations-693C→A, 854A→C, and 914C→A-were identified in the coding sequence. The 693C→A and 914C→A base changes, resulting in nonsense tyr231→ter and missense ala305→glu mutations, respectively, lead to complete loss of ASPA activity in in vitro expression studies. The 854A→C transversion converted glu to ala in codon 285. The glu285→ala mutant ASPA has 2.5% of the activity expressed by the wild-type enzyme. A fourth mutation, 433 -2(A→G) transition, was identified at the splice-acceptor site in intron 2. The splice-site mutation would lead to skipping of exon 3, accompanied by a frameshift, and thus would produce aberrant ASPA. Of the 128 unrelated Canavan chromosomes analyzed, 88 were from probands of Ashkenazi Jewish descent. The glu285→ala mutation was predominant (82.9%) in this population, followed by the tyr231→ter (14.8%) and 433 -2(A→G) (1.1%) mutations. The three mutations account for 98.8% of the Canavan chromosomes of Ashkenazi Jewish origin. The ala305→glu mutation was found exclusively in non-Jewish probands of European descent and constituted 60% of the 40 mutant chromosomes. Predominant occurrence of certain mutations among Ashkenazi Jewish and non-Jewish patients with Canavan disease would suggest a founding-father effect in propagation of these mutant chromosomes.

AB - Canavan disease is an autosomal recessive leukodystrophy caused by the deficiency of aspartoacylase (ASPA). Sixty-four probands were analyzed for mutations in the ASPA gene. Three point mutations-693C→A, 854A→C, and 914C→A-were identified in the coding sequence. The 693C→A and 914C→A base changes, resulting in nonsense tyr231→ter and missense ala305→glu mutations, respectively, lead to complete loss of ASPA activity in in vitro expression studies. The 854A→C transversion converted glu to ala in codon 285. The glu285→ala mutant ASPA has 2.5% of the activity expressed by the wild-type enzyme. A fourth mutation, 433 -2(A→G) transition, was identified at the splice-acceptor site in intron 2. The splice-site mutation would lead to skipping of exon 3, accompanied by a frameshift, and thus would produce aberrant ASPA. Of the 128 unrelated Canavan chromosomes analyzed, 88 were from probands of Ashkenazi Jewish descent. The glu285→ala mutation was predominant (82.9%) in this population, followed by the tyr231→ter (14.8%) and 433 -2(A→G) (1.1%) mutations. The three mutations account for 98.8% of the Canavan chromosomes of Ashkenazi Jewish origin. The ala305→glu mutation was found exclusively in non-Jewish probands of European descent and constituted 60% of the 40 mutant chromosomes. Predominant occurrence of certain mutations among Ashkenazi Jewish and non-Jewish patients with Canavan disease would suggest a founding-father effect in propagation of these mutant chromosomes.

UR - http://www.scopus.com/inward/record.url?scp=0028085633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028085633&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 34

EP - 41

JO - American Journal of Human Genetics

JF - American Journal of Human Genetics

SN - 0002-9297

IS - 1

ER -